In 2015, it was clearly demonstrated in a cohort of 91,726 individuals that a low-prevalence loss-of-function mutation in ABCA1 was significantly associated with low plasma apoE levels, and with high risk of Alzheimer’s disease and cerebrovascular disease [74]. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.